Per-olof Wallstrom
Board of Director
Biotechnology
Hansa Medical
Sweden
Biography
Per-Olof has extensive experience from various positions in the international pharmaceutical and biotechnology industry, including Senior Management positions at Merck, Astra, Pharmacia and Bristol-Myers Squibb. In addition, he has served as CEO of Q-Med AB, Melacure Therapeutics AB and Karo Bio AB. Per-Olof is also director of the boards at Camurus AB (Chairman), MB Eriksson Bygg och Fastighet AB (Chairman) and Arosia Communication AB and Patients Pending Ltd. (Chairman). Per-Olof holds an M.Sc. in Pharmacy from Uppsala University. Born 1949. Per-Olof is member of the Hansa Medical Audit committee and of the Remuneration Committee Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.
Research Interest
Pharmaceutical and Biotechnology Industry
